Hytera Leads Enhanced Development of Push-to-Talk over Cellular Industry
SHENZHEN, China--(BUSINESS WIRE)--#Hytera--The Push-to-Talk over Cellular (PoC) radio market has expanded rapidly in the last few years. PoC offers instant...
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Fine Craft Co., Ltd.: Excellent Sharpness. Launch of NiNJA at Kickstarter, a Special Japanese Kitchen Knife That Adds Sustainability to Design as an Added Value
GIFU, Japan--(BUSINESS WIRE)--Fine Craft Co., Ltd., headquartered in Japan has launched a reasonably priced, high-grade kitchen knife called "NiNJA" on...
Wipro Annual Report 2020 on Form 20-F Available Online for ADS Holders
EAST BRUNSWICK, N.J. & BANGALORE, India--(BUSINESS WIRE)--#ADSHolders--Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting...
FDA Accepts Shionogi’s Supplemental New Drug Application with Priority Review for FETROJA® (cefiderocol) for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced the U.S. Food and Drug Administration...
Kingold Jewelry Announces Appointment of Yi Huang as Acting CFO
WUHAN CITY, China--(BUSINESS WIRE)--Kingold Jewelry, Inc. ("Kingold" or the "Company") (NASDAQ: KGJI), one of China's leading manufacturers and designers of...
Celanese Signs Technology Licensing Agreement for Acetic Acid Route to Acrylic Acid
A key step to commercialize acetic acid-to-acrylic acid technology DALLAS & SHANGHAI--(BUSINESS WIRE)--$CE #Celanese--Celanese Corporation (NYSE: CE), a global chemical...
VideoProc Summer Deals Kicks Off with Coupons and Extra Cash Back Reward
CHENGDU, China--(BUSINESS WIRE)--$USD #cash--Digiarty VideoProc announces official online deals in the summer shopping season that kick off with Cash Back...
Samsung Announces New NAND Flash Facility to Address Future Data Center and Mobile Demands
Located inside Pyeongtaek's Line 2 in Korea, the new facility is slated for mass production in 2H 2021 The facility...
Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time
Pre-clinical data for Celltrion’s antiviral antibody treatment candidate demonstrate a 100-fold reduction in viral load of SARS-CoV-2 (COVID-19), as well...
YouTube Entrepreneur Matt Par to Host a Free Training Webinar That Will Help Millennials Monetize Their Channels
SAN FRANCISCO--(BUSINESS WIRE)--19-year-old YouTube expert Matt Par has created a free training webinar for wannabe content creators looking to get...
Global Leading Institutions Took Stakes in Yeahka, Showing Confidence in Its Long-Term Prospects
HONG KONG--(BUSINESS WIRE)--YEAHKA LIMITED, China’s leading payment and business service technology platform commences trading on the Main Board of The...
ViaBTC Group Announces Strategic Upgrade to Advance Innovation and Improve Customer Experience
HONG KONG--(BUSINESS WIRE)--ViaBTC Group, an innovative technology company specialized in blockchain and dedicated to providing users with comprehensive digital asset...
Crash Barrier Systems Market 2020-2024 | Implementation of Road Safety Programs to Boost Market Growth | Technavio
LONDON--(BUSINESS WIRE)--#CrashBarrierSystemsMarket--The crash barrier systems market is expected to grow by USD 1.29 billion during 2020-2024. The report also provides...
ENHERTU® Demonstrated Meaningful Clinical Activity in Patients with HER2 Mutant Non-Small Cell Lung Cancer in Interim Analysis of Phase 2 DESTINY-Lung01 Trial
61.9% of patients with HER2 mutant metastatic non-small cell lung cancer treated with ENHERTU achieved a tumor response Breakthrough Therapy...
ENHERTU® Achieved a Tumor Response Rate of 45.3% in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial
TOKYO & BASKING RIDGE, N.J. & MUNICH--(BUSINESS WIRE)--Results from the phase 2 DESTINY-CRC01 trial of Daiichi Sankyo Company, Limited (hereafter,...
